Telix Submits Biologics License Application (BLA) for TLX250

Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer

Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Belgium , Japan , United Kingdom , Switzerland , Melbourne , Victoria , Australia , Canada , Australian , Alvin Carrie Meinhardt , Brian Shuch , James Stonecypher , Christian Behrenbruch , Cdx Zircaix , Kyahn Williamson , Telix Pharmaceuticals , Telix Group , Telix Pharmaceuticals Limited Disclosure Committee , Kidney Cancer Program , Drug Administration , Kidney Cancer Research , Prnewswire Telix Pharmaceuticals Limited , Health Canada , Australian Securities Exchange , Corporate Communications , Australian Therapeutic Goods Administration , Institute Of Urologic Oncology , Pharmaceuticals Limited , Biologics License Application , Breakthrough Therapy , Priority Review , Managing Director , Chief Development Officer , Carrie Meinhardt Endowed Chair , Urologic Oncology , Telix Pharmaceuticals Limited ,